Impact of treatment heterogeneity on drug resistance and supply chain costs
Year of publication: |
2013
|
---|---|
Authors: | Spiliotopoulou, Eirini ; Boni, Maciej F. ; Yadav, Prashant |
Published in: |
Socio-economic planning sciences : the international journal of public sector decision-making. - Amsterdam [u.a.] : Elsevier, ISSN 0038-0121, ZDB-ID 208905-1. - Vol. 47.2013, 3, p. 158-171
|
Subject: | Treatment heterogeneity | Drug resistance | Drug assortment | Costs of variety | Healthcare supply chains | Lieferkette | Supply chain | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs | Gesundheitsversorgung | Health care | Drogenkonsum | Drug consumption | Pharmaindustrie | Pharmaceutical industry | Droge | Drug | Drogenpolitik | Drug policy |
-
Active postmarketing drug surveillance for multiple adverse events
Goh, Joel, (2015)
-
Blum, Richard H., (1969)
-
(2021)
- More ...
-
Impact of treatment heterogeneity on drug resistance and supply chain costs
Spiliotopoulou, Eirini, (2013)
-
Hofstra, Nienke, (2024)
-
Managing and reallocating inventory across two markets with local information
Spiliotopoulou, Eirini, (2018)
- More ...